- Home
- IPHA vs AHMA Comparison
IPHA vs AHMA Comparison
Compare IPHA & AHMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPHA | AHMA |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | France | United Arab Emirates |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.2M | 150.1M |
| IPO Year | 2019 | 2025 |
Fundamental Metrics
Financial Performance| Metric | IPHA | AHMA |
|---|---|---|
| Price | $1.70 | $24.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | 26.6K | ★ 2.6M |
| Earning Date | 09-17-2025 | 12-08-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | $14,839,695.00 | ★ $19,771,050.00 |
| Revenue This Year | $22.29 | N/A |
| Revenue Next Year | $43.90 | N/A |
| P/E Ratio | ★ N/A | $593.89 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.63 | $4.00 |
| 52 Week High | $2.63 | $31.07 |
Technical Indicators
Market Signals| Indicator | IPHA | AHMA |
|---|---|---|
| Relative Strength Index (RSI) | 46.43 | N/A |
| Support Level | $1.72 | N/A |
| Resistance Level | $1.86 | N/A |
| Average True Range (ATR) | 0.08 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 39.39 | 0.00 |
Price Performance
Historical ComparisonAbout IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About AHMA Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares
Ambitions Enterprise Management Co LLC, through its subsidiaries in the UAE, operates as a tour operator, travel agency, and event planning and management services provider. It provides two lines of services, namely, MICE management, a comprehensive coordination and organization of events, and one-stop tourism, a comprehensive travel product that is designed to provide tourists with all the necessary components of a trip in a single and convenient package, which typically include transportation, accommodations, meals, and guided tours or activities.